拓普药业 (837631.OC)

+ 收藏

现金流量表(拓普药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 36,438,838.4046,966,449.4629,505,719.3368,833,463.0650,942,813.45
 收到的税费返还(元) 948,838.921,943,281.021,188,659.843,313,643.30273,240.00
 收到其他与经营活动有关的现金(元) 626,097.401,517,502.50132,285.195,924,225.211,172,915.87
 经营活动现金流入小计(元) 38,013,774.7250,427,232.9830,826,664.3678,071,331.5752,388,969.32
 购买商品、接受劳务支付的现金(元) 21,729,804.8421,599,042.2817,556,816.9955,484,759.7340,520,827.78
 支付给职工以及为职工支付的现金(元) 5,672,125.979,104,427.305,075,447.7910,791,830.185,991,877.83
 支付的各项税费(元) 1,748,466.942,708,326.06686,774.221,115,570.131,476,246.25
 支付其他与经营活动有关的现金(元) 4,075,457.388,804,606.675,117,599.263,596,768.362,351,770.21
 经营活动现金流出小计(元) 33,225,855.1342,216,402.3128,436,638.2670,988,928.4050,340,722.07
 经营活动产生的现金流量净额(元) 4,787,919.598,210,830.672,390,026.107,082,403.172,048,247.25
二、投资活动产生的现金流量
 取得投资收益收到的现金(元) 20,803.9222,289.9422,289.9433,434.9133,434.91
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) ---26,764.02-
 投资活动现金流入小计(元) 20,803.9222,289.9422,289.9460,198.9333,434.91
 购建固定资产、无形资产和其他长期资产支付的现金(元) 7,957,872.845,217,012.00801,950.093,191,272.952,547,230.15
 投资活动现金流出小计(元) 7,957,872.845,217,012.00801,950.093,191,272.952,547,230.15
 投资活动产生的现金流量净额(元) -7,937,068.92-5,194,722.06-779,660.15-3,131,074.02-2,513,795.24
三、筹资活动产生的现金流量
 取得借款收到的现金(元) 20,000,000.0010,000,000.00-15,000,000.00-
 筹资活动现金流入小计(元) 20,000,000.0010,000,000.00-15,000,000.00-
 偿还债务支付的现金(元) 10,000,000.0015,000,000.00-15,000,000.00-
 分配股利、利润或偿付利息支付的现金(元) 272,000.00588,245.82372,287.505,687,919.80393,675.00
 筹资活动现金流出小计(元) 10,272,000.0015,588,245.82372,287.5020,687,919.80393,675.00
 筹资活动产生的现金流量净额(元) 9,728,000.00-5,588,245.82-372,287.50-5,687,919.80-393,675.00
四、汇率变动对现金及现金等价物的影响(元) 133.831,094.893,335.724.92-
五、现金及现金等价物净增加额(元) 6,578,984.50-2,571,042.321,241,414.17-1,736,585.73-859,222.99
 加:期初现金及现金等价物余额(元) 6,579,345.759,149,388.079,149,388.0710,885,973.8010,885,973.80
 期末现金及现金等价物余额(元) 13,158,330.256,578,345.7510,390,802.249,149,388.0710,026,750.81
补充资料:
 净利润(元) 1,367,391.161,826,783.902,144,184.179,800,470.495,908,159.74
 资产减值准备(元) 198,293.38469,546.76--277,804.57171,539.92
 固定资产和投资性房地产折旧(元) 2,058,554.524,193,322.732,079,852.933,778,684.171,850,773.34
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 2,058,554.524,193,322.732,079,852.933,778,684.171,850,773.34
 无形资产摊销(元) 276,221.45440,384.32241,154.96468,976.44121,152.96
 处置固定资产、无形资产和其他长期资产的损失(元) ---65,563.98-
 财务费用(元) 276,832.84578,213.43368,951.78687,914.88393,675.00
 投资损失(元) -20,803.92-22,289.94-22,289.94-33,434.91-33,434.91
 递延所得税(元) -750,038.76-59,823.08146,629.72-84,864.57
  其中:递延所得税资产减少(元) -750,038.76-59,823.08146,629.72-84,864.57
 存货的减少(元) 9,662,998.29-3,009,681.41-147,618.07-10,977,084.013,557,900.39
 经营性应收项目的减少(元) -8,947,094.405,942,280.431,358,950.85-6,494,218.39-11,407,838.33
 经营性应付项目的增加(元) -260,580.00-3,540,121.62-4,086,725.8110,616,432.211,571,183.71
 现金的期末余额(元) 13,158,330.256,578,345.7510,390,802.249,149,388.0710,026,750.81
 减:现金的期初余额(元) 6,579,345.759,149,388.079,149,388.0710,885,973.8010,885,973.80
 现金及现金等价物的净增加额(元) 6,578,984.50-2,571,042.321,241,414.17-1,736,585.73-859,222.99
公告日期 2024-08-262024-04-262023-08-212023-04-262022-08-26
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院